Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel and Carboplatin with or without Low-Dose Radiation in Head and Neck Cancer
NCT02126969Phase 2Completed
- Start
- Oct 2014
- Primary completion
- Mar 2018
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel, carboplatin in head and neck squamous cell carcinoma (HNSCC). Started Oct 2014; status: completed.
02
Drugs
docetaxelcarboplatin
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT02126969.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02126969.